Innovative Nanoparticles for ex vivo and in vivo Genome Editing
Innovative Nanoparticles to deliver mRNA for Vaccination
European Society of Gene and Cell Therapy ESGCT 30th Annual Congress, Brussels
Nicolas Grandchamp will be at the European Society of Gene and Cell Therapy ESGCT 30th Annual Congress, October 24-27 2023, Brussels. He will take advantage of this congress to present our latest results concerning the use of our property mRNA delivery platforms in genome editing.
GEG Tech and EPFL signed a collaborative research agreement
Brisken Lab, EPFL, and GEG Tech have established a collaboration in the field of breast cancer. Breast cancer affects one women in twelve during her lifetime and is now the cancer the most widely in the world (WHO 2021). The design of new therapeutic strategies against breast cancer is a huge challenge and represents a […]
World Vaccine Congress Europe, Barcelonna
Happy to announce the presence of Nicolas Grandchamp at the World Vaccine Congress Europe, October 17-19, 2023, Barcelona. He will take advantage of this congress to present our latest results concerning the use of our property mRNA delivery platforms in vaccination.
ISCT 2023, Paris
We are pleased to announce the presence of our CSO, Nicolas Grandchamp, PhD at the ISCT congress in Paris, from May 31 to June 3.
GEG Tech and University Industry Foundation, Yonsei University Health System signed a collaborative research agreement
GEG Tech is proud to announce that a two-year collaborative research agreement has been sign with University Industry Foundation, Yonsei University Health System (YUHS). The purpose of this agreement is to establish a collaboration for research toward vectorization of the prime editing system for gene therapy. YUHS will be responsible for evaluation of the potential […]
GEG-Tech Signs Distribution Agreement with Tebu-Bio
GEG-tech’s agreement with tebu-bio expands the distribution of advanced vectorisation systems & tools, designed by GEG-tech (genetic engineering lab) into the European Market. GEG-tech, the technology leader in advanced lentiviral vectorisation systems, announces a distribution agreement with tebu-bio to bolster its coverage of the European Market. tebu-bio, is a pan-european distributor of speciality real agents […]
Innovation in cancerology: meeting in Monaco
GEG Tech will be attending the 14th Biennale Monegasque de Cancerologie. It will take place at the end on Januray 2020 in Monaco. More than 1300 participants will be gathering and discussing the evolution and progresses of cancerology. Various themes will be discussed, among them last innovations and new molecules, news in hematology, access to […]
Gene therapy: An Extensive Overview
Recent advances in the field of genetic engineering are expanding the capability of gene therapy to treat diseases, notably those previously unreachable. As a proof, the last two years saw the number of marketing authorization for gene therapy products significantly rise. Last month, Novartis has obtained Canadian approvement for its CAR-T Therapy, Kymriah. For its […]